Submit a Manuscript to the Journal
Journal of Chemotherapy
For an Article Collection on
New Therapeutics for Breast Cancer Treatment
Manuscript deadline
Article collection guest advisor(s)
Andrea Bonetti,
Pederzoli Hospital
andrea.bonetti@ospedalepederzoli.it
Ida Landini,
Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence
ida.landini@unifi.it
Enrico Mini,
Department of Preclinical and Clinical Pharmacology, University of Florence
enrico.mini@unifi.it
New Therapeutics for Breast Cancer Treatment
Breast cancer is the most common malignancy in women and the second leading cause of cancer related death. It is a molecularly diverse disease. Heterogeneity can be observed in a wide range of cell types with varying morphology and molecular traits. The heterogeneity of this disease presents a big challenge in its therapeutic treatment.
Guidelines generally determine the treatment of breast cancer according to cancer subtypes: for example, hormone receptor-positive (luminal), triple-negative (basal-like), and HER2-overexpressing breast cancer.
Besides the traditional treatments, such as hormone therapy, radiotherapy, and chemotherapy, innovative approaches have improved breast cancer treatments, which comprise targeted therapies and immunotherapy. Among them, potent therapeutics based on molecular pathways, such as small-molecule inhibitors, monoclonal antibodies and antibody-drug conjugates, or on immune modulation, such as immune checkpoint inhibitors, CAR T cell therapy, and cancer vaccines. Tumor microenvironment -targeted therapies may also contribute to the development of new therapeutic strategies.
The aim of this special collection is to provide an overview of clinical developments and recent advancements in targeted therapies and immunotherapies for breast cancer treatment. The successes, challenges, and perspectives will be critically reported and discussed, covering new and emerging therapeutic areas and ongoing clinical trials that may result in further improvement in breast cancer outcomes.
The Article Publishing Charge (APC) can be calculated via the Open Access Cost Finder.
Benefits of publishing open access within Taylor & Francis
Global marketing and publicity, ensuring your research reaches the people you want it to.
Article Collections bring together the latest research on hot topics from influential researchers across the globe.
Rigorous peer review for every open access article.
Rapid online publication allowing you to share your work quickly.
Submission Instructions
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.